dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Ravimiamet
Sissetulev kiriAvalik

Küsimused

Ravimiamet · 6. mai 2025
Viit
MSO-13/2285-1
Registreeritud
6. mai 2025
Dokumendi liik
Sissetulev kiri
Adressaat
Comac Medical
Saabumis/saatmisviis
e-post
Funktsioon
MSO Meditsiiniseadmed
Sari
MSO-13 Meditsiiniseadmete kliiniliste uuringute ja toimivusuuringute dokumendid (taotlused, load, muud teavitused ja kirjavahetus)
Toimik
MSO-13/2025
Vastutaja
Merili Saar-Abroi (RA, Meditsiiniseadmete osakond)

Failid

  • 📎_POTENTIAL PHISHING_patient fee limits in clinical trials.msg173 KB

Sisu (failidest)

Saatja: Katarzyna Stankiewicz <[email protected]> Saaja: Merili Saar-Abroi Teema: [POTENTIAL PHISHING]patient fee limits in clinical trials Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Merili, Could you please be so kind and help me with one issue. If there is some legal act/ regulation in your country regarding patient compensation fee limits in clinical trials? Sponsor will reimbursement the costs - travel cost for patients and I need to provide him information if there are some limits regulations in your country. Thank you for support. Best regards, Kasia -- Katarzyna Stankiewicz RA and Start-up Specialist I | Contracting Specialist II Mobile: +48512369646 <tel:+359123456789> <tel:+35928921000> Email: [email protected] <mailto:[email protected]> <https://comac-medical.com/> <https://comac-medical.com/> <https://www.linkedin.com/company/comac-medical/mycompany/> <https://comac-medical.com/events/> Please think before you print. In accordance with the internal company rules, emails sent or received in the evening, at the weekend and during periods of suspension of the contract (holidays, sick leave, etc.) do not call for immediate response. This communication may contain information that is proprietary, confidential, or exempt from disclosure. If you are not the intended recipient, please note that any other dissemination, distribution, use or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer.
Allikas: Ravimiamet dokumendiregister →